The Fundamental Difference
The most important difference between the two dosage forms lies in how the active ingredient enters the body and acts. For general information on efficacy, see Finasteride: Efficacy & Clinical Studies. With oral administration (tablet), finasteride is absorbed through the gastrointestinal tract, enters the blood, and distributes throughout the body, where it acts systemically and lowers dihydrotestosterone (DHT) in scalp, blood, brain, and prostate. DHT is an important factor in androgenetic alopecia. Oral 1-mg products have long clinical experience.
With topical application, finasteride is applied to the scalp and acts more locally at the application site. Systemic absorption depends on concentration, amount, frequency and product. A physician therefore needs to assess whether a topical form is appropriate in the individual case.
Efficacy Comparison
Numerous clinical studies have investigated the efficacy of both dosage forms. Research results show a differentiated picture.
Phase III Study Shows Comparable Results
The most important comparative study was published in 2022. [2] This randomized, controlled Phase III study compared 0.25% topical finasteride spray with 1 mg oral finasteride over 24 weeks:
| Parameter | Topical (0.25%) | Oral (1 mg) |
|---|---|---|
| Hair Count Increase | Comparable | Comparable |
| Serum DHT Reduction | 34.5% | 55.6% |
| Sexual Side Effects | 2.8% | 4.8% |
| Application | Daily application | Daily swallowing |
Most important finding: Hair count improvement was comparable in both forms, but topical finasteride showed significantly lower systemic DHT reduction and fewer side effects. [1] [2]
Long-Term Efficacy in the Data
An early 16-month study investigated topical 0.005% finasteride in 52 participants in a placebo-controlled, single-blind design. [4] The authors reported encouraging results for hair regrowth and reduction of balding areas, without evidence of relevant percutaneous absorption or local/systemic adverse effects. Because of the study's size and age, the data should be interpreted cautiously.
By comparison, oral 1-mg studies show improvement or stabilization in 90 to 95% after 12 to 24 months. 5 to 10% show progressive hair loss.
Studies provide relevant data for both dosage forms. Which form is medically appropriate depends on benefits, risks, tolerability and personal context.
Dosage with Topical Finasteride
A critical point: Not all topical finasteride formulations are equal. Systemic absorption depends on several factors that are crucial for efficacy and side effect profile.
Factors of Systemic Absorption
Systemic absorption depends on several factors: concentration (percent finasteride in solution), volume (amount in milliliters per application), frequency (once or twice daily), and carriers (penetration enhancers in formulation). A study showed the direct relationship of these factors. [3]
At 0.091 mg daily, no measurable DHT changes in blood are detectable. At 0.273 mg daily, minimal DHT reduction of about 10% occurs. At 2.275 mg daily, DHT reduction is comparable to oral administration.
Systemic absorption is dose-dependent. Concentration, amount and frequency should therefore be set by a physician, not self-selected.
Topical Dosages Studied
Different topical concentrations have been studied. [6] [7] Lower concentrations may reduce systemic absorption, while higher concentrations can mean stronger local exposure and more systemic absorption.
A physician should decide which concentration and amount are appropriate in an individual case.
Detailed Advantages and Disadvantages
Both dosage forms have specific advantages and disadvantages that should be considered in the decision.
| Criterion | Oral (Tablet) | Topical (Solution) |
|---|---|---|
| Efficacy | Long clinical experience with oral 1-mg dosing | Studies with comparable hair-count improvement and lower DHT reduction in blood |
| Application | Tablet use according to medicinal product information or prescription | Application according to medicinal product information or prescription |
| Systemic Effects | DHT reduction throughout body | Lower DHT reduction in blood, primarily local action |
| Side Effects | Higher risk for systemic side effects | Significantly fewer systemic side effects reported |
| Clinical Data | Comprehensive clinical data since 1997 | Shorter clinical experience but growing evidence |
| Treatment Area | No targeted treatment of specific areas possible | Targeted treatment of affected areas possible |
| Practical Aspects | Simple application, caution with desire to conceive (sperm quality) | Can make hair and scalp oily, avoid direct skin contact for pregnant women and children |
Want to stop hair loss and regrow your hair?
Get startedWhich Factors Are Assessed Medically?
The choice between oral and topical application depends on medical baseline, benefit-risk assessment, tolerability, and personal preferences. Detailed information on side effects can be found in our article Finasteride Side Effects.
Oral Form: Possible Considerations
Oral finasteride products have long clinical experience and simple use. At the same time, the oral form acts systemically. A physician should take desire to conceive, concomitant medication, side effects, liver disease, and personal risk factors into account.
Topical Form: Possible Considerations
Topical forms can allow local application and reduce systemic absorption. Whether this is medically appropriate depends on product, concentration, amount, treatment area, skin tolerability, and personal context.
Individual Approach
The choice of dosage form and dose should be made by a physician and based on your individual situation. A cautious start can be reasonable in certain cases, but it is not a general dosing recommendation.
Lower-dose topical solutions may reduce systemic absorption. Whether they work sufficiently and whether a combination with other active ingredients such as minoxidil is appropriate should be decided medically.
With advanced hair loss or insufficient response, other concentrations, combinations, or an oral form may be medically assessed. Regular follow-ups help evaluate efficacy and tolerability.
Combination with Minoxidil
Both oral and topical finasteride forms can be combined with minoxidil if a physician considers this appropriate in the individual case. A meta-analysis of seven randomized studies found better hair density, hair diameter, and photographic assessment results for topical minoxidil-finasteride combinations compared with minoxidil alone. [8] Individual studies are not fully consistent: in a small 12-week study with 0.1% topical finasteride plus 5% minoxidil, there was no significant added benefit over minoxidil alone. [9]
Both active ingredients have different mechanisms: finasteride reduces DHT, while minoxidil influences growth phases. A physician should decide whether the combination, product, and application schedule are suitable.
Availability in Switzerland
Finasteride has been available in Switzerland as an oral medication for treating androgenetic alopecia since the late 1990s. [1] [2] Since late 2022, with Fynzur, a topical dosage form has also been approved as a prescription-only finished medicinal product. [6]
For hair loss treatment, various oral 1 mg finasteride preparations are available in Switzerland: Finasterid-Mepha Procapil, Propecia, Andropecia, and Biorga. As a topical option, Fynzur Spray is approved, specifically for mild to moderate hair loss in men between 18 and 41 years. [6]
Specialized providers like orva can also enable individual prescriptions in collaboration with pharmacies if a physician prescribes them. These may contain finasteride in various concentrations and, when medically indicated, be combined with active ingredients such as minoxidil.
Conclusion on Choosing the Right Dosage Form
There's no universal answer to the question of the right dosage form. The decision depends on medical suitability, product, benefits, risks, tolerability, and personal preferences.
The oral form has the longest clinical experience and is simple to use, but it acts systemically.
Topical application may reduce systemic absorption, but it depends more strongly on formulation, amount, treatment area, and application.
For more information, see our articles on Finasteride Side Effects, Finasteride Efficacy & Studies and Finasteride Prescription Switzerland. You can also start directly with our online consultation or learn more about Minoxidil as a complementary treatment.
References
- [1] Hafner J, Läuchli S. (2023). Androgenetische Alopezie: Mehr Therapien für mehr Haare. Rosenfluh Publikationen. https://www.rosenfluh.ch/media/congressselection/2023/02/Androgenetische-Alopezie-Mehr-Therapien-fuer-mehr-Haare.pdf (Accessed 08.10.2025)
- [2] Piraccini BM, Blume-Peytavi U, Scarci F, et al.. (2022). Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III randomized, controlled clinical trial. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.17738
- [3] Caserini M, Radicioni M, Leuratti C, Annoni O, Palmieri R. (2014). A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers. International Journal of Clinical Pharmacology and Therapeutics. https://pubmed.ncbi.nlm.nih.gov/25074865/ (Accessed 10.10.2025)
- [4] Mazzarella F, Loconsole F, Cammisa A, Mastrolonardo M, Vena GA. (1997). Topical finasteride in the treatment of androgenic alopecia. Preliminary evaluations after a 16-month therapy course. Journal of Dermatological Treatment. https://doi.org/10.3109/09546639709160517
- [5] Suchonwanit P, Iamsumang W, Rojhirunsakool S. (2019). Efficacy of topical combination of 0.25% finasteride and 3% minoxidil versus 3% minoxidil solution in female pattern hair loss: a randomized, double-blind, controlled study. American Journal of Clinical Dermatology. https://pubmed.ncbi.nlm.nih.gov/30484271/ (Accessed 12.10.2025)
- [6] Trüeb RM. (2023). Androgenetische Alopezie: Fein-Tuning der Therapien mit Finasterid und Minoxidil. Rosenfluh Publikationen - Dermatologie & Ästhetische Medizin. https://www.rosenfluh.ch/media/dermatologie-aesthetische-medizin/2023/02/Androgenetische-Alopezie-Fein-Tuning-der-Therapien-mit-Finasterid-und-Minoxidil.pdf (Accessed 13.10.2025)
- [7] Trüeb RM. (2011). Androgenetische Alopezie beim Mann. Dermatologie Ostschweiz. https://www.dermaostschweiz.ch/wp-content/uploads/2016/10/AGA-2011.pdf (Accessed 13.10.2025)
- [8] Li Y, Huang Q, Zhou Z, Zhang Y. (2025). Comparing minoxidil-finasteride mixed solution with minoxidil solution alone for male androgenetic alopecia: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Medicine. https://doi.org/10.3389/fmed.2025.1632139
- [9] Lubis FF, Legiawati L, Saulina M, Saldi SRF. (2025). Randomized controlled trial on the efficacy and safety of the combination therapy of topical 0.1% finasteride - 5% minoxidil in male androgenetic alopecia. Archives of Dermatological Research. https://doi.org/10.1007/s00403-025-04216-9